# Rosetta Capital Limited

Rosetta Capital Limited is an Asset Manager based in Haddenham, United Kingdom.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Haddenham, United Kingdom
- **Region:** Europe
- **Address:** London, United Kingdom
- **Founded:** 2002
- **Assets under management:** Undisclosed
- **Website:** www.rosetta-capital.com
- **LinkedIn:** https://www.linkedin.com/company/rosettacapital

## Regulatory record

- **CRD number:** 168176
- **SEC file number:** 802-80322
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/168176

## About

Life Sciences Venture Capital Investor | Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Our investment approach is global, building leading healthcare companies and groundbreaking technologies with the potential to enhance human lives. Our primary focus is direct secondary transactions, offering adaptable liquidity solutions to investors and corporations.

## Sectors

- Healthcare
- Life Sciences
- MedTech
- Biotech

## People

- John Scott — Partner
- Andrew Muir — Partner

## Questions

### What is the firm's geographic focus?

Rosetta Capital invests exclusively in Europe, with a particular emphasis on the UK, Ireland, and Western Europe. It does not invest outside the continent. This geographic constraint has been consistent since the firm's founding in 2002.

### Which sectors does Rosetta Capital explicitly avoid?

Rosetta Capital explicitly avoids any sectors outside healthcare and life sciences. It does not invest in technology, software, fintech, clean energy, or any other non-healthcare vertical. The firm's mandate also excludes investments outside Europe.

### How does Rosetta Capital source proprietary deal flow?

The firm sources deals through a network of European university technology transfer offices, hospitals, and existing portfolio company referrals. Its long tenure and sector specialization provide repeat deal flow from institutional co-investors. The small team reviews hundreds of opportunities annually to select three to five new investments per year.

## Related profiles

- [VanderPol Investments](https://altss.com/profile/vanderpol-investments-llc)
- [Moser Capital Management](https://altss.com/profile/moser-capital-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/rosetta-capital-limited

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology